Ibnsina Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ISPH?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	92,829,048	9.21%
Institutions	238,558,917	23.7%
Individual Insiders	262,186,991	26%
General Public	414,425,044	41.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 9 shareholders own 58.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14%	Faisal Islamic Bank of Egypt, Asset Management Arm	140,981,127	ج.م941.8m	0%	92.51%
9.68%	European Bank for Reconstruction and Development, Asset Management Arm	97,577,790	ج.م651.8m	0%	1.65%
9.21%	Blom Bank, Investment Arm	92,829,048	ج.م620.1m	4.86%	100.0%
8.12%	Mohamed Mohsen Mahgoub	81,829,167	ج.م546.6m	0%	no data
5.91%	Omar Abdel-Gawad	59,532,063	ج.م397.7m	6.25%	no data
4.91%	Mahmoud Abdel-Gawad	49,515,566	ج.م330.8m	2.06%	no data
4.61%	Ahmed Abdelgawad Mahmoud	46,465,615	ج.م310.4m	0%	no data
2.31%	Mohamed Abbas Mohamed Zaki	23,323,081	ج.م155.8m	-13.8%	no data
0.15%	Abdel Aziz Abdel Aziz	1,521,499	ج.م10.2m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 00:58
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ibnsina Pharma is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Neveen Ghonima	Beltone Financial
Aly Adel	Beltone Financial
Alia El Mehelmy	CI Capital Research